Methods of measuring susceptibility of anaerobic bacteria to trovafloxacin, including quality control parameters

被引:4
作者
Barry, AL
Fuchs, PC
Thornsberry, C
McLaughlin, JC
Jenkins, SG
Hardy, DJ
Allen, SD
机构
[1] MICROBIOL REFERENCE LAB,FRANKLIN,TN 37064
[2] UNIV NEW MEXICO,ALBUQUERQUE,NM 87106
[3] UNIV FLORIDA,MED CTR,JACKSONVILLE,FL 32209
[4] UNIV ROCHESTER,ROCHESTER,NY 14642
[5] INDIANA UNIV,MED CTR,INDIANAPOLIS,IN 46202
关键词
D O I
10.1007/BF01691158
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Three methods approved by the National Committee for Clinical Laboratory Standards for testing the susceptibility of anaerobic bacteria were used to evaluate the fluoroquinolone, trovafloxacin. The methods gave essentially comparable results with 126 anaerobes and with three quality control strains. A collaborative study defined the quality control range for trovafloxacin MICs. Trovafloxacin had good in vitro activity against the more common anaerobes (MIC 90 less than or equal to 2.0 mu g/ml).
引用
收藏
页码:676 / 678
页数:3
相关论文
共 7 条
[1]   METHODS FOR TESTING THE SUSCEPTIBILITY OF ANAEROBIC-BACTERIA TO 2 FLUOROQUINOLONE COMPOUNDS, PD-131628 AND CLINAFLOXACIN [J].
BARRY, AL ;
FUCHS, PC ;
CITRON, DM ;
ALLEN, SD ;
WEXLER, HM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 (06) :893-900
[2]   INVITRO ACTIVITY OF CP-99,219, A NEW FLUOROQUINOLONE, AGAINST CLINICAL ISOLATES OF GRAM-POSITIVE BACTERIA [J].
ELIOPOULOS, GM ;
KLIMM, K ;
ELIOPOULOS, CT ;
FERRARO, MJ ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (02) :366-370
[3]   INVITRO ANTIMICROBIAL ACTIVITY OF CP-99,219, A NOVEL AZABICYCLO-NAPHTHYRIDONE [J].
GOODING, BB ;
JONES, RN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (02) :349-353
[4]  
GOODING BB, 1993, ANTIMICROBIAL AGENTS, V38, P909
[5]  
National Committee for Clinical Laboratory Standards, 1993, M11A3 NCCLS
[6]   IN-VITRO ACTIVITY OF THE NEW FLUOROQUINOLONE CP-99,219 [J].
NEU, HC ;
CHIN, NX .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (11) :2615-2622
[7]   ACTIVITY OF CP 99,219 COMPARED WITH THOSE OF CIPROFLOXACIN, GREPAFLOXACIN, METRONIDAZOLE, CEFOXITIN, PIPERACILLIN, AND PIPERACILLIN-TAZOBACTAM AGAINST 489 ANAEROBES [J].
SPANGLER, SK ;
JACOBS, MR ;
APPELBAUM, PC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (10) :2471-2476